Long-term safety of Daclizumab Beta in patients with relapsing MS in EXTEND: Interim results from treatment up to 6 yearsS. Cohan,L. Kappos, J. Holman,H. Chen, S. Fam,B. ParksMULTIPLE SCLEROSIS JOURNAL（2017）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
